< Back to search
Filter
1
Active & Responsive

Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research

for
Cutaneous T-cell Lymphoma, Sezary Syndrome, Mycosis Fungoides,
Location: Pittsburgh PA
Sponsor: University of Pittsburgh

Sex: All

Age: 18+

Code: NCT00177268

Recruiting
Active & Responsive

Zanubrutinib and Lisocabtagene Maraleucel for the Treatment of Richter's Syndrome

for
Recurrent Transformed Chronic Lymphocytic Leukemia,
Location: New York NY, Columbus OH, Salt Lake City UT
Sponsor: Aseel Alsouqi

Sex: All

Age: 18+

Code: NCT05873712

Phase 2, Recruiting
Active & Responsive

A Study of Oral MBQ-167 in Participants With Advanced Breast Cancer

for
Breast Cancer, Breast Neoplasm, Breast Cancer Stage IV
Location: Sarasota FL, Nashville TN, Beverly Hills CA
Sponsor: MBQ Pharma

Sex: All

Age: 21+

Code: NCT06075810

Phase 1, Recruiting
Active & Responsive

RFA of Benign Thyroid Nodules: Clinical Outcomes and Quality of Life Study

for
Thyroid Nodules
Location: New York NY
Sponsor: Columbia University

Sex: All

Age: 18+

Code: NCT05189314

Recruiting
Active & Responsive

Safety and Preliminary Efficacy of Pumitamig (BNT327), an Investigational Therapy for Patients With Non-small Cell Lung Cancer in Combination With Chemotherapy as First-line or Second-line Treatment

for
Non-small Cell Lung Cancer
Location: New York NY, Tampa FL, Elizabethtown KY, Birmingham AL
Sponsor: BioNTech SE

Sex: All

Age: 18+

Code: NCT06841055

Phase 2, Recruiting

Interested in new solid tumors trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

Topical or Oral Minoxidil for the Treatment of Endocrine Therapy-Induced Alopecia in Patients With Stage I-IV Breast Cancer

for
Anatomic Stage I Breast Cancer AJCC v8,
Location: Columbus OH
Sponsor: Ohio State University Comprehensive Cancer Center

Sex: Female

Age: 18+

Code: NCT05417308

Early Phase 1, Recruiting
Active & Responsive

DNAJB1-PRKACA Fusion Kinase Peptide Vaccine Combined With Nivolumab and Ipilimumab for Patients With Fibrolamellar Hepatocellular Carcinoma

for
Fibrolamellar Hepatocellular Carcinoma (FLC)
Location: Baltimore MD
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Sex: All

Age: 12+

Code: NCT04248569

Phase 1, Recruiting
Active & Responsive

99mTc Sestamibi SPECT/CT vs 18F Fluorocholine PET/CT

for
Parathyroid Adenoma
Location: Stanford CA
Sponsor: Andrei Iagaru

Sex: All

Age: 18+

Code: NCT05891769

Phase 2, Phase 3, Recruiting
Active & Responsive

A Study of Venetoclax in Combination With Isatuximab and Dexamethasone for Relapsed/Refractory Multiple Myeloma

for
Multiple Myeloma in Relapse, Multiple Myeloma, Refractory
Location: Omaha NE, West Hollywood CA
Sponsor: Oncotherapeutics

Sex: All

Age: 0+

Code: NCT06115135

Phase 2, Recruiting
Active & Responsive

Epcoritamab-CAR T Cells for Large B-cell Lymphomas

for
Lymphoma, Non-Hodgkin, Relapsed Diffuse Large B Cell Lymphoma,
Location: Philadelphia PA
Sponsor: Abramson Cancer Center at Penn Medicine

Sex: All

Age: 18+

Code: NCT06458439

Phase 2, Recruiting
Active & Responsive

Study of Iberdomide, Bortezomib, Dexamethasone With Isatuximab Added on Demand for ND-NTE MM Patients

for
Multiple Myeloma
Location: St. John's, Halifax, Montreal, Toronto, London,
Sponsor: Canadian Myeloma Research Group

Sex: All

Age: 65+

Code: NCT05272826

Phase 2, Recruiting
Active & Responsive

Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer

for
Advanced Non-squamous Non-small-cell Lung Cancer,
Location: Mullica Hill NJ, Miami FL, Plantation FL,
Sponsor: Genelux Corporation

Sex: All

Age: 18+

Code: NCT06463665

Phase 2, Recruiting
Active & Responsive

ONC206 for Treatment of Newly Diagnosed, Recurrent Diffuse Midline Gliomas, and Other Recurrent Malignant CNS Tumors

for
Diffuse Midline Glioma (DMG), Glioblastoma,
Location: Philadelphia PA, Washington D.C. DC, Atlanta GA,
Sponsor: Sabine Mueller, MD, PhD

Sex: All

Age: 2 - 21

Code: NCT04732065

Phase 1, Recruiting
Active & Responsive

Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)

for
Hematologic Malignancy, GvHD, GVHD,Acute, GVHD, Chronic,
Location: Boston MA, New York NY, Minneapolis MN, Seattle WA,
Sponsor: Tr1X, Inc.

Sex: All

Age: 18+

Code: NCT06462365

Phase 1, Recruiting
Active & Responsive

Adenovirus (RGDCRAdCOX2F)

for
Adenocarcinoma of Pancreas
Location: Minneapolis MN
Sponsor: Masonic Cancer Center, University of Minnesota

Sex: All

Age: 18+

Code: NCT06693986

Phase 1, Recruiting
Active & Responsive

Frequency and Clinical Phenotype of BAP1 Hereditary Predisposition Syndrome

for
Uveal Melanoma, Cutaneous Melanoma, BAP1 Gene Mutation,
Location: Columbus OH
Sponsor: Mohamed Abdel-Rahman

Sex: All

Age: 0+

Code: NCT04792463

Recruiting
Active & Responsive

DRP-104 (Glutamine Antagonist) in Combination With Durvalumab in Patients With Advanced Stage Fibrolamellar Carcinoma (FLC)

for
Fibrolamellar Hepatocellular Carcinoma
Location: Baltimore MD
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Sex: All

Age: 12+

Code: NCT06027086

Phase 1, Phase 2, Recruiting
Active & Responsive

A Prospective, Multi-center, Observational Study for Signal-C Test Evaluation

for
Colorectal Cancer, Advanced Adenocarcinoma
Location: Raonoke VA
Sponsor: Universal Diagnostics

Sex: All

Age: 45 - 70+

Code: NCT06059963

Recruiting
Active & Responsive

Maternal Cancer Diagnosis and Treatment During Pregnancy:a Database for Maternal, Fetal, and Neonatal Outcomes

for
Pregnancy, Cancer, Cancer in Pregnancy, Gestational Breast Cancer, Pregnancy Related,
Location: Camden NJ
Sponsor: The Cooper Health System

Sex: Female

Age: 0+

Code: NCT02749474

Recruiting
Active & Responsive

FIGO 2018 Stage IB2 Cervical Cancer Treated With Neoadjuvant Chemotherapy Followed by Fertility Sparing Surgery

for
Cervical Cancer
Location: Quebec, Toronto
Sponsor: University Health Network, Toronto

Sex: Female

Age: 18 - 40

Code: NCT04016389

Recruiting